Skip to main content
MedWatcherBeta

Loading research and source information…

A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes for Type 2 diabetes: evidence and status · MedWatcher